NAT-SITAGLIPTIN
NATCO PHARMA (CANADA) INC
Quick answers
Is there a shortage of NAT-SITAGLIPTIN in Canada?
No. There is no current shortage of NAT-SITAGLIPTIN 25MG reported to Health Canada. Stock can still vary from one pharmacy to another.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Closest Matches
SITAGLIPTIN
SIVEM PHARMACEUTICALS ULC
PMS-SITAGLIPTIN
PHARMASCIENCE INC
Other Products
APO-SITAGLIPTIN
APOTEX INC
JANUVIA
MERCK CANADA INC
PRZ-SITAGLIPTIN
PHARMARIS CANADA INC
NAT-SITAGLIPTIN
NATCO PHARMA (CANADA) INC
DIN
02558157
Strength
25MG
Dosage Form
Tablet
Route
Oral
Active Ingredient
SITAGLIPTIN (SITAGLIPTIN PHOSPHATE MONOHYDRATE)
See all SITAGLIPTIN (SITAGLIPTIN PHOSPHATE MONOHYDRATE) products →Compare with another product →
Product Monograph
Product monograph is not available from Health Canada
Shortage History
No shortage or discontinuation reports on file for this product.
Other Products from NATCO PHARMA (CANADA) INC
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
250MG · DIN 02494132
1MG · DIN 02417855
5MG · DIN 02492822
2.5MG · DIN 02492814
100MG · DIN 02496895
25MG · DIN 02496887
62.5MG · DIN 02467984
125MG · DIN 02467992
20MG · DIN 02496488
10MG · DIN 02496461
40MG · DIN 02409038
20MG · DIN 02409011